Deltex Medical Group plc reported earnings results for the half year ended June 30, 2024. For the half year, the company reported sales was GBP 1.06 million compared to GBP 1.06 million a year ago. Net loss was GBP 0.546 million compared to GBP 0.537 million a year ago. Basic loss per share from continuing operations was GBP 0.0003 compared to GBP 0.0008 a year ago. Diluted loss per share from continuing operations was GBP 0.0003 compared to GBP 0.0008 a year ago.